Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01707303 · ClinicalTrials.gov registry record · NA

Effect Of Acute Inflammatory Mediators On Functional Limitations In Patients With Acute Respiratory Failure

A NA study, sponsored by Wake Forest University.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT01707303 is a NA study that has completed, run by Wake Forest University. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01707303, a NA study, has completed, sponsored by Wake Forest University.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

This is a randomized, controlled, pilot study of two separate Cohorts of patients from the intensive care unit. Cohort I will enroll 50 patients and randomize to receive one physical therapy session per day or receive usual ICU care. Cohort II, will enroll an additional 50 patients and randomize to receive either two physical therapy sessions per day or usual care. Outcome will be length of hospital stay measured in days. Secondary outcomes will be mortality, ventilator days, ICU days, and for Cohort II, grip strength, dynamometer strength assessments and the short physical performance battery (SPPB). Study subjects will have blood for cytokine analysis through their first week of study.

Interventions

  • OTHER Usual Care
  • OTHER Early ICU rehabilitation strategies

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2007-07
Est. Completion 2009-08
Phase NA

Sponsor

Wake Forest University

100 total trials

What the Registry Record Tells You About NCT01707303

The ClinicalTrials.gov registry entry for NCT01707303 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.

NCT01707303 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01707303 about?

NCT01707303 is a clinical study titled "Effect Of Acute Inflammatory Mediators On Functional Limitations In Patients With Acute Respiratory Failure". This is a randomized, controlled, pilot study of two separate Cohorts of patients from the intensive care unit. Cohort I will enroll 50 patients and randomize to receive one physical therapy session per day or receive usual ICU care. Cohort II, will enroll an additional 50 patients and randomize to ...

What is the current status of trial NCT01707303?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2007-07. Estimated completion is 2009-08.

What interventions are being tested in trial NCT01707303?

The interventions under investigation include: Usual Care (OTHER), Early ICU rehabilitation strategies (OTHER).

Who is sponsoring clinical trial NCT01707303?

This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.